Pharmacokinetics of teniposide (VM26) and etoposide (VP16-213) in children with cancer
- 1 April 1982
- journal article
- Published by Springer Science and Business Media LLC in Cancer Chemotherapy and Pharmacology
- Vol. 7 (2-3), 147-150
- https://doi.org/10.1007/bf00254537
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Clinical evaluation of sequentially scheduled cisplatin and vm26 in neuroblastoma: Response and toxicityCancer, 1981
- Analysis of the anticancer drugs VP 16-213 and VM 26 and their metabolites by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemiaCancer, 1980
- Sensitivity of normal and neoplastic cells to chemotherapeutic agents in vitro.1980
- Conformational analysis of podophyllotoxin and its congeners. Structure-activity relationship in microtubule assemblyJournal of Medicinal Chemistry, 1979
- A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximationJournal of Pharmacokinetics and Biopharmaceutics, 1978
- Nonenolizable podophyllotoxin derivativesJournal of Medicinal Chemistry, 1977
- Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotoxin glucopyranoside derivativesEuropean Journal of Cancer (1965), 1975
- Assessment of Pharmacokinetic Constants from Postinfusion Blood Curves Obtained after I.V. InfusionJournal of Pharmaceutical Sciences, 1970
- The Biological Effects and the Chemical Composition of Podophyllin. A ReviewJNCI Journal of the National Cancer Institute, 1954